Drug Shortage Report for CETROTIDE

Last updated on 2020-12-11 History
Report ID 128858
Drug Identification Number 02247766
Brand name CETROTIDE
Common or Proper name cetrorelix acetate
Company Name EMD SERONO, A DIVISION OF EMD INC., CANADA
Market Status MARKETED
Active Ingredient(s) CETRORELIX
Strength(s) 0.25MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 vial
ATC code H01CC
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-11-24
Estimated end date
Actual end date 2020-12-10
Shortage status Resolved
Updated date 2020-12-11
Company comments Resolved.
Health Canada comments
Tier 3 Status No
Contact Address 2695 NORTH SHERIDAN WAY, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5K 2N6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-11-24 English Compare
v2 2020-11-24 French Compare
v3 2020-11-25 English Compare
v4 2020-12-10 English Compare
v5 2020-12-10 English Compare
v6 2020-12-10 English Compare
v7 2020-12-10 French Compare
v8 2020-12-10 English Compare
v9 2020-12-10 French Compare
v10 2020-12-10 English Compare
v11 2020-12-10 French Compare
v12 2020-12-11 English Compare

Showing 1 to 12 of 12